Dose-reduced first cycle of chemotherapy for prevention of life-threatening acute complications in nonseminomatous germ cell tumor patients with ultra high tumor markers and/or poor performance status.

导出 LinkOut

翻译打印收藏纠错

第一作者： Alexey,Tryakin

第一单位： Department of Clinical Pharmacology and Chemotherapy, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, 115478, Russia. atryakin@mail.ru.

作者： Alexey,Tryakin ^[1] ; Mikhail,Fedyanin ^[2] ; Anatoly,Bulanov ^[2] ; Shalva,Kashia ^[3] ; Ildar,Kurmukov ^[3] ; Vsevolod,Matveev ^[4] ; Igor,Fainstein ^[5] ; Olga,Gordeeva ^[6] ; Tatjana,Zakharova ^[7] ; Sergei,Tjulandin ^[2]

作者单位： Department of Clinical Pharmacology and Chemotherapy, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, 115478, Russia. atryakin@mail.ru. ^[1] Department of Clinical Pharmacology and Chemotherapy, N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, 115478, Russia. ^[2] Intensive Care Unit, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia. ^[3] Urology Department, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia. ^[4] Radiosurgery Department, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia. ^[5] Department of Chemotherapy and Combined Treatment of Malignant Tumors, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia. ^[6] Pathology Department, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia. ^[7]

关键词 Choriocarcinoma, non-gestational Extensive tumor burden Induction chemotherapy Nonseminomatous germ cell tumor Poor risk Testicular cancers Ultra-high tumor markers